NCT01385917View on ClinicalTrials.gov

Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping

UnknownOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Duchenne Muscular Dystrophy
Trial Locations (2)

Unknown

RECRUITING

Myology Institute, Paris

WC1N 1EH

RECRUITING

Great ormond Street Hospital & University College London Hospital, London

Sponsors

Lead Sponsor

Genethon
All Listed Sponsors
collaborator

Institute of Myology

OTHER

lead

Genethon

OTHER

NCT01385917 - Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping | Biotech Hunter | Biotech Hunter